Takeda presents phase III PhALLCON trial data at ASCO Plenary Series Program

Obesity affects children’s likelihood of survival after cancer diagnosis, study finds

A recent population-based study indicates that among children with cancer, those with obesity at the time of diagnosis may face an elevated risk of dying. The findings are published by Wiley online in CANCER.

January 17, 2025

Vol.51 No.02

Clinical Roundup

CAR T-cell therapy obe-cel demonstrates high response rates in advanced B-cell ALL

Patients with relapsed or refractory CD19-positive B-cell acute lymphoblastic leukemia who were treated with the novel anti-CD19 chimeric antigen receptor T-cell therapy, obecabtagene autoleucel, experienced high response rates and most did not need a subsequent stem cell transplant, according to results from the phase Ib/II FELIX trial co-led by researchers at the University of Texas MD Anderson Cancer Center.

December 06, 2024

Vol.50 No.45

Clinical Roundup

Report examines outcomes in children with Down syndrome and ALL

Children with Down syndrome have an increased risk of developing acute lymphoblastic leukemia and experience higher rates of relapse and treatment toxicity. In recent decades, new therapies have improved outcomes for the general population, but outcomes for children with Down syndrome have lagged and have not been reported for contemporary treatment regimens.

November 03, 2023

Vol.49 No.41

Takeda presents phase III PhALLCON trial data at ASCO Plenary Series Program

YOU MAY BE INTERESTED IN

Obesity affects children’s likelihood of survival after cancer diagnosis, study finds

CAR T-cell therapy obe-cel demonstrates high response rates in advanced B-cell ALL

Report examines outcomes in children with Down syndrome and ALL

Renew today!

Subscriber content

Never miss an issue!

Login